Meconium aspiration syndrom

Reading File

Finding Sources

Searching PubMed

"meconium aspiration syndrome"[MeSH Terms]

Searching Images

meconium aspiration syndrome chest X-ray CXR newborn

Reading File

Loading Image

I now have comprehensive information from three authoritative textbooks plus imaging. Let me compile the full answer.

Meconium Aspiration Syndrome (MAS)

Definition

MAS is a clinical diagnosis defined by three criteria occurring together:

Delivery through meconium-stained amniotic fluid (MSAF)
Respiratory distress in the newborn
A characteristic chest X-ray appearance

Meconium is confirmed by its presence below the level of the vocal cords.

Creasy & Resnik's Maternal-Fetal Medicine, p. 1789

Epidemiology

MSAF occurs in 4%-22% of all deliveries; more frequent in post-term gestation (>42 weeks)
Intrauterine meconium passage is unusual before 36 weeks (requires maturation of intestinal smooth muscle and myenteric plexus)
Only 1%-2% of deliveries with MSAF are complicated by MAS
MAS is most common in post-mature (post-term) infants

Pathophysiology

MAS is no longer considered a simple obstructive disease. Multiple mechanisms operate simultaneously:

1. Mechanical Airway Obstruction

Meconium is thick and tenacious - it migrates to the distal airways causing:

Complete obstruction → segmental atelectasis
Partial obstruction ("ball-valve" effect) → air trapping and overinflation
Alternating areas of atelectasis and hyperinflation on imaging

2. Chemical Pneumonitis

Meconium directly irritates the bronchial mucosa and lung parenchyma, triggering inflammation.

3. Surfactant Inactivation

Meconium inactivates surfactant, worsening alveolar collapse and V/Q mismatch.

4. Pulmonary Hypertension (PPHN)

Chronic fetal hypoxia causes increased muscle in distal pulmonary arterial vessels (vascular remodeling)
This leads to persistent pulmonary hypertension of the newborn (PPHN), which is the most dangerous complication
The normal postnatal drop in pulmonary vascular resistance (PVR) fails to occur
Right-to-left shunting across the ductus arteriosus and foramen ovale persists → severe hypoxemia

Diagram of muscle extension in pulmonary arterial branches in MAS with PPHN

Figure: In infants with MAS + PPHN, muscle extends into the most peripheral (intra-acinar) pulmonary arteries - Barash's Clinical Anesthesia, p. 3581

Fetal Trigger

Clinical experience indicates that a stressed/hypoxic fetus passes meconium prior to birth. Infants born through MSAF are more likely to have:

Lower umbilical cord pH
Non-reassuring fetal heart rate tracings
Perinatal asphyxia

Clinical Features

Severe MAS hallmarks:

Need for positive-pressure ventilation
Presence of pulmonary hypertension (PPHN)
Cyanosis disproportionate to lung findings

Complications:

Air leak (pneumothorax, pulmonary interstitial emphysema) - common
Small pleural effusions
Chronic lung disease
Developmental delay
Mortality (significant in severe disease)

Chest X-Ray Findings

Classic radiographic features:

Bilateral hyperinflation (due to air trapping)
Asymmetrical coarse opacification (patchy infiltrates) - chemical pneumonitis
Small pleural effusions
Alternating atelectasis and overinflation

CXR of infant born at 42 weeks with MAS - bilateral hyperinflation, small left pleural effusion, and asymmetric coarse opacification

Fig. 70.13: Infant born at 42 weeks showing bilateral hyperinflation, small left pleural effusion, and asymmetrical coarse opacification - Grainger & Allison's Diagnostic Radiology, p. 1765

Prevention Strategies

Obstetric Prevention

Induction of labor at 41 weeks reduces MSAF and MAS compared to expectant management
Amnioinfusion to dilute thick meconium did NOT reduce MAS incidence when peripartum surveillance was adequate

Peripartum Suctioning - Evolved Recommendations

Era	Recommendation
1970s - 2005	Aggressive airway suctioning (obstetrician + neonatologist)
2004	Large RCT showed no benefit of intrapartum suctioning
Post-2005	Perineal/nasopharyngeal suctioning abandoned
2015 (ILCOR/AAP)	No routine endotracheal suctioning for either vigorous OR depressed infants
Current	Focus on prompt positive-pressure ventilation if needed

Key principle: Delaying positive-pressure ventilation (to perform suctioning) causes more harm than benefit. Personnel skilled in ventilation should attend any expected depressed delivery.

Management

Treatment is directed at managing hypoxemia and respiratory failure:

Respiratory Support

Positive-pressure ventilation in ~30% of affected infants
Conventional mechanical ventilation with lung-protective strategy
High-frequency oscillatory ventilation in refractory cases

Pulmonary Vasodilators (for PPHN)

Agent	Route	Notes
Inhaled nitric oxide (iNO)	Inhaled	Selective pulmonary vasodilator; first-line for PPHN
Sildenafil	Oral/IV	PDE-5 inhibitor
Bosentan	Oral	Endothelin receptor antagonist

These agents also allow less injurious ventilator strategies, reducing air leak and chronic lung disease.

Surfactant

Early exogenous surfactant is a useful treatment modality (counteracts inactivation by meconium)

Extracorporeal Membrane Oxygenation (ECMO)

Used when conventional treatments fail:

VA-ECMO (veno-arterial): cannulas via internal jugular vein + common carotid artery; bypasses pulmonary circulation when PVR is very high
VV-ECMO (veno-venous): double-lumen catheter via internal jugular vein; used for isolated respiratory failure

Term infant with MAS on ECMO - bilateral pneumothoraces with chest drains

Fig. 70.14: Term infant with MAS on VV-ECMO following bilateral pneumothoraces - Grainger & Allison's Diagnostic Radiology, p. 1765

Antibiotics and Steroids

Selectively used - no demonstrated effectiveness in clinical trials.

Outcome

Mortality and morbidity have dramatically improved with iNO and ECMO
Severe MAS remains associated with: air leaks, chronic lung disease, developmental delay
The overall incidence of MAS has declined at many centers with improved obstetric surveillance and abandonment of routine suctioning

Key Points Summary

Feature	Detail
Incidence	1-2% of MSAF deliveries
Peak risk	Post-term (>42 weeks), fetal distress
Core mechanisms	Obstruction + surfactant inactivation + chemical pneumonitis + PPHN
Worst complication	PPHN (persistent pulmonary hypertension)
CXR finding	Bilateral hyperinflation + coarse asymmetric opacities
Routine suctioning	NOT recommended (current ILCOR/AAP guidelines)
Key treatment	iNO for PPHN; surfactant; PPV; ECMO as rescue

Sources:

Creasy & Resnik's Maternal-Fetal Medicine, 8e, pp. 1789-1790
Grainger & Allison's Diagnostic Radiology, pp. 1765-1766
Barash, Cullen & Stoelting's Clinical Anesthesia, 9e, pp. 3580-3582

Recent evidence note: A 2023 meta-analysis (PMID 35016248) confirmed no benefit of endotracheal suctioning in infants born through MSAF, consistent with current guidelines. A 2025 systematic review (PMID 39541964) on respiratory conditions in newborns in low/middle-income countries highlights ongoing management challenges in resource-limited settings.

This is a shared conversation. Sign in to Orris to start your own chat.